R. Scorza

发表

The Functional Polymorphism 844 A>G in FcαRI (CD89) Does Not Contribute to Systemic Sclerosis or Rheumatoid Arthritis Susceptibility

Javier Martín, M. Coenen, P. V. van Riel, 2011, The Journal of Rheumatology.

Sudden Unexpected Death in ParkinsonÃ¢ÂÂs Disease and thePharmacological Modulation of the Ca2+/cAMP Signaling Interaction: AShot of Good News

ro Bueno Bergantin, S. Francisco, A. Caricati‐Neto, 2017 .

Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression

Jane Worthington, Javier Martín, M. Coenen, 2010, The Journal of Rheumatology.

Polymorphisms in the Interleukin 4, Interleukin 13, and Corresponding Receptor Genes Are Not Associated with Systemic Sclerosis and Do Not Influence Gene Expression

Jane Worthington, Javier Martín, M. Coenen, 2012, The Journal of Rheumatology.

Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR)

Jane Worthington, B. Alizadeh, Javier Martín, 2010, The Journal of Rheumatology.

The of Rheumatology Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Correction: Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A

Jane Worthington, B. Alizadeh, Javier Martín, 2010 .

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.

L. Joosten, M. Mayes, J. Reveille, 2014, The New England journal of medicine.

Unique digital skin lesions associated with systemic sclerosis

E. Berti, A. Marzano, R. Scorza, 1997, The British journal of dermatology.

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

Annette Lee, P. Gregersen, R. Ophoff, 2010, Nature Genetics.